AI perception of JAK Inhibitors in Atopic Dermatitis | LucidScope AI Visibility Audit
Key Findings from the LucidScope AI Visibility Analysis Rinvoq dominates AI…
Bionyra Pharma Launches With $165M to Advance Immunology Biologics | Lucid Diligence Brief
Bionyra Pharma launched with $165M to advance TL1A, IL-23 and IL-25 biologics…
AbbVie's Apogee Acquisition Valued at $10.9B. | Lucid Diligence Brief
AbbVie’s Apogee deal adds zumilokibart and asthma assets as immunology growth…
Immunology Today—June 24, 2026
This week’s Immunology update highlights regulatory approvals, advancing late-…
Immunology Today—June 17, 2026
This week’s Immunology update highlights regulatory progress, late-stage…
Immunology Today—June 3, 2026
This week’s Immunology update highlights regulatory and clinical developments…
Immunology Today—April 29, 2026
This week’s Immunology update highlights regulatory actions, clinical progress,…
Immunology Today—April 22, 2026
This week’s Immunology update highlights regulatory progress, clinical pipeline…
Respiratory Today—April 17, 2026
This week’s Respiratory Research update highlights regulatory momentum,…
Immunology Today—April 8, 2026
This week’s Immunology update highlights regulatory and portfolio shifts, mid-…
Immunology Today—April 1, 2026
This week’s Immunology update highlights regulatory progress, late-stage…